Analysis of the Quality of Reporting of Randomized Controlled Trials in Acute and Chronic Myeloid Leukemia, and Myelodysplastic Syndromes as Governed by the CONSORT Statement

Annals of Epidemiology

Volumn 19, Issue 7, 2009, Pages 494-500

  Ziogas, Dimitrios C ^a   Zintzaras, Elias ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

CONSORT; Hematologic Malignancy; Methodology; Myelodysplastic Syndromes; Myeloid Leukemia; Quality; Randomized Controlled Trials

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; MEDLINE; METHODOLOGY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; VALIDATION PROCESS;

DISCLOSURE; GUIDELINE ADHERENCE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MYELODYSPLASTIC SYNDROMES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC;

EID: 66449118578     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2009.03.018     Document Type: Article

References (37)

1. Djulbegovic B., Loughran T., Hornung C.A., Kloecker G., Efthimiadis E.N., Hadley T.J., et al. The quality of medical evidence in hematology-oncology. Am J Med 106 (1999) 198-205
2. Moher D., Jadad A.R., and Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 12 (1996) 195-208
3. Altman D.G. Better reporting of randomised controlled trials: the CONSORT statement. BMJ 313 (1996) 570-571
4. Kober T., Trelle S., and Engert A. Reporting of Randomized Controlled Trials in Hodgkin Lymphoma in Biomedical Journals. J Natl Cancer Inst 98 (2006) 620-625
5. Bonadonna G., and Valagussa P. Influence of clinical trials on current treatment strategy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 19 (1990) 209-218
6. Pfeifer M., and Snodgrass G.L. The continued use of retracted invalid scientific literature. JAMA 263 (1999) 1420-1423
7. Olkin I. Meta-analysis: reconciling the results of independent studies. Stat Med 14 (1995) 457-472
8. Moher D., Pham B., Jones A., Cook D.J., Jadad A.R., Moher M., Tugwell P., and Klassen T.P. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 352 (1999) 609-613
9. Schulz K.F., Chalmers I., Hayes R.J., and Altman D.G. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995) 408-412
10. Begg C., Cho M., Eastwood S., Horton R., Moher D., Olkin I., et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276 (1996) 637-639
11. Mills E., Wu P., Gagnier J., and Devereaux P.J. The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp Clin Trials 26 (2005) 480-487
12. Juni P., Altman D.G., and Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323 (2001) 42-46
13. Hotopf M., Lewis G., and Normand C. Putting trials on trial-the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health 51 (1997) 354-358
14. Liberati A., Himel H.N., and Chalmers T.C. A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 4 (1986) 942-951
15. Pildal J., Hrobjartsson A., Jorgensen K.J., Hilden J., Altman D.G., and Gotzsche P.C. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 36 (2007) 847-857
16. Moher D., Schulz K.F., Altman D.G., and CONSORT GROUP (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 134 (2001) 657-662
17. Moher D., Schulz K.F., Altman D., and CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285 (2001) 1987-1991
18. Altman D.G., Schulz K.F., Moher D., Egger M., Davidoff F., Elbourne D., et al., CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 (2001) 663-694
19. Rennie D. CONSORT revised-improving the reporting of randomized trials. JAMA 285 (2001) 2006-2007
20. Moher D., Simera I., Schulz K.F., Hoey J., and Altman D.G. Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research. BMC Med 6 (2008) 13
21. Moher D., Jones A., and Lepage L. Use of the CONSORT Statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 285 (2001) 1992-1995
22. Plint A., Moher D., Morrison A., Schulz K., Altman D.G., Hill C., and Gaboury I. Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. Med J Aust 185 (2006) 263-267
23. Rennie D. How to report randomized controlled trials: the CONSORT statement. JAMA 276 (1996) 649
24. McNamee D., and Horton R. Lies, damn lies, and reports of RCTs. Lancet 348 (1996) 562
25. Lai T.Y., Wong V.W., Lam R.F., Cheng A.C., Lam D.S., and Leung G.M. Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol 14 (2007) 390-398
26. Agha R., Cooper D., and Muir G. The reporting quality of randomised controlled trials in surgery: a systematic review. Int J Surg 5 (2007) 413-422
27. Hill C.L., Buchbinder R., and Osborne R. Quality of reporting of randomized clinical trials in abstracts of the 2005 annual meeting of the American College of Rheumatology. J Rheumatol 34 (2007) 2476-2480
28. Farrokhyar F., Chu R., Whitlock R., and Thabane L. A systematic review of the quality of publications reporting coronary artery bypass grafting trials. Can J Surg 50 (2007) 266-277
29. Soares H., Daniels S., Kumar A., Clarke M., Scott C., Swann S., et al. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ 328 (2004) 22-24
30. Mills E., Loke Y.K., Wu P., Montori V.M., Perri D., Moher D., and Guyatt G. Determining the reporting quality of RCTs in clinical pharmacology. Br J Clin Pharmacol 58 (2004) 61-65
31. Le Henanff A., Giraudeau B., Baron G., and Ravaud P. Quality of reporting on noninferiority and equivalence randomized trials. JAMA 295 (2006) 1147-1151
32. Piaggio G., Elbourne D., Altman D., Pocock S.J., and Evans S.J. CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 295 (2006) 1152-1160
33. Colditz G., Miller J.N., and Mosteller F. How study design affects outcomes in comparisons of therapy. Stat Med 8 (1989) 441-454
34. Huwiler-Müntener K., Jüni P., Junker C., and Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 287 (2002) 2801-2804
35. Hill C., LaValley M.P., and Felson D.T. Discrepancy between published reports and actual conduct of randomized clinical trials. J Clin Epidemiol 55 (2002) 783-786
36. Altman D.G. Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ 330 (2005) 1056-1057
37. Moher D., Fortin P., Jadad A.R., Jüni P., Klassen T., Le Lorier J., et al. Completeness of reporting of trials published in languages other than English: implications for the conduct of systematic reviews. Lancet 347 (1996) 363-366